Ascendis Pharma A (ASND) Other Non-Current Assets (2012 - 2021)

Ascendis Pharma A (ASND) has 10 years of Other Non-Current Assets data on file, last reported at $2.0 million in Q3 2021.

• For the quarter ending Q3 2021, Other Non-Current Assets rose 39.13% year-over-year to $2.0 million; the trailing twelve-month figure through Sep 2021 stood at $2.0 million (up 39.13% YoY), and the FY2020 full-year result was $1.6 million, changed 0.06% from the prior year.
• Other Non-Current Assets declined to $2.0 million in Q3 2021, from $2.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.0 million in Q2 2021 to a low of $284463.6 in Q1 2017.
• A 5-year average of $1.3 million and a median of $1.4 million in 2020 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets declined 13.17% in 2017 and jumped 380.25% in 2018, its largest moves.
• Tracing ASND's Other Non-Current Assets over 5 years: stood at $344987.7 in 2017, then jumped by 283.13% to $1.3 million in 2018, then climbed by 22.52% to $1.6 million in 2019, then advanced by 1.24% to $1.6 million in 2020, then grew by 23.22% to $2.0 million in 2021.
• Business Quant data shows ASND's Other Non-Current Assets at $2.0 million in Q3 2021, $2.0 million in Q2 2021, and $1.6 million in Q4 2020.